United States Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-Commercial/R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-House Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Vector Production, Others), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical/Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (FACS, ELISA, Chromatography, PCR, Others), Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. United States Cell and Gene Therapy Manufacturing QC Market, By Therapy Type 2022-2034 (USD MILLION/ Units)
    1. Cell Therapy
      1. CAR-T
        1. Autologous CAR-T
        2. Allogeneic CAR-T
      2. CAR-NK
      3. B-Cell
      4. Others
    2. Gene Therapy
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Other
      2. Non-Viral
  2. United States Cell and Gene Therapy Manufacturing QC Market, By Scale 2022-2034 (USD MILLION/ Units)
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. United States Cell and Gene Therapy Manufacturing QC Market, By Mode 2022-2034 (USD MILLION/ Units)
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. United States Cell and Gene Therapy Manufacturing QC Market, By Workflow 2022-2034 (USD MILLION/ Units)
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. United States Cell and Gene Therapy Manufacturing QC Market, By Process 2022-2034 (USD MILLION/ Units)
    1. Upstream Processes
    2. Downstream Processes
  6. United States Cell and Gene Therapy Manufacturing QC Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    2. Biopharmaceutical / Biotechnological Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    3. Contract Manufacturing Organizations
      1. Small Size
      2. Medium Size
      3. Large Size
  7. United States Cell and Gene Therapy Manufacturing QC Market, By Technology Type 2022-2034 (USD MILLION/ Units)
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
  8. Regional United States Cell and Gene Therapy Manufacturing QC Market
    1. U.S.
      1. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      2. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      3. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      4. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      5. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      6. U.S. United States Cell and Gene Therapy Manufacturing QC Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      7. U.S. United States Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others

We are featured on: